Rivastigmine
CAS 123441-03-2
Overview
Rivastigmine is a cholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease and Parkinson's. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects, which typically include nausea and vomiting
Anant Labs manufacture and furnish high quality Rivastigmine impurities for global markets. Our Rivastigmine EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
CAS123441-03-2
Mol. FormulaC14H22N2O2
Mol. Weight250.342 g/mol
IUPAC[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate
SMILESCCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C
InChIInChI=1S/C14H22N2O2/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4/h7-11H,6H2,1-5H3/t11-/m0/s1
InChI KeyXSVMFMHYUFZWBK-NSHDSACASA-N
Note: We are upgrading our system, Cat No will change.
Synonyms
rivastigmine123441-03-2PrometaxENA 713 free baseNimvastidRivastigmine Tevarivastigmine hexalSDZ-ENA-713RivastigminaSDZ-212-713
